![Charles Gersbach](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Gersbach
Corporate Officer/Principal chez Duke University
Profil
Charles Gersbach is the founder of Locus Biosciences, Inc. which was founded in 2015.
Currently, he is an Associate Professor at Duke University since 2009.
He previously worked as a Director at Element Genomics, Inc.
Postes actifs de Charles Gersbach
Sociétés | Poste | Début |
---|---|---|
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01/07/2015 |
Anciens postes connus de Charles Gersbach
Sociétés | Poste | Fin |
---|---|---|
Element Genomics, Inc.
![]() Element Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Element Genomics, Inc. engages in healthcare services. The company was founded in 2015 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
Locus Biosciences, Inc.
![]() Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Locus Biosciences, Inc.
![]() Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
Element Genomics, Inc.
![]() Element Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Element Genomics, Inc. engages in healthcare services. The company was founded in 2015 and is headquartered in Durham, NC. | Commercial Services |